EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Metabolic pathways and antimicrobial peptide resistance in bacteria

Mohammed Elbediwi iD, Jens Rolff

Journal of Antimicrobial Chemotherapy · 01.07.2024 · 79 (7) · 1473-1483

DOI: 10.1093/jac/dkae128 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Antimicrobial Chemotherapy, online erschienen am 14.05.2024. Verfasst von Mohammed Elbediwi und 1 weiteren Autor:innen. Beteiligte Einrichtung: Evolutionary Biology, Institute for Biology, Freie Universität Berlin, 14195 Berlin, Germany. Hauptthemen laut MEDLINE: Bacteria, Metabolic Networks and Pathways, Drug Resistance, Bacterial, Antimicrobial Peptides. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 131 Literaturangaben. Gefördert von: Freie Universität Berlin.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Antimicrobial resistance is a pressing concern that poses a significant threat to global public health, necessitating the exploration of alternative strategies to combat drug-resistant microbial infections. Recently, antimicrobial peptides (AMPs) have gained substantial attention as possible replacements for conventional antibiotics. Because of their pharmacodynamics and killing mechanisms, AMPs display a lower risk of bacterial resistance evolution compared with most conventional antibiotics. However, bacteria display different mechanisms to resist AMPs, and the role of metabolic pathways in the resistance mechanism is not fully understood. This review examines the intricate relationship between metabolic genes and AMP resistance, focusing on the impact of metabolic pathways on various aspects of resistance. Metabolic pathways related to guanosine pentaphosphate (pppGpp) and guanosine tetraphosphate (ppGpp) [collectively (p)ppGpp], the tricarboxylic acid (TCA) cycle, haem biosynthesis, purine and pyrimidine biosynthesis, and amino acid and lipid metabolism influence in different ways metabolic adjustments, biofilm formation and energy production that could be involved in AMP resistance. By targeting metabolic pathways and their associated genes, it could be possible to enhance the efficacy of existing antimicrobial therapies and overcome the challenges exhibited by phenotypic (recalcitrance) and genetic resistance toward AMPs. Further research in this area is needed to provide valuable insights into specific mechanisms, uncover novel therapeutic targets, and aid in the fight against antimicrobial resistance.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BacteriaMetabolic Networks and PathwaysDrug Resistance, BacterialAntimicrobial PeptidesHumansAnti-Bacterial AgentsBiofilms

Substanzen

Antimicrobial PeptidesAnti-Bacterial Agents

Autor:innen und Institutionen

  • Evolutionary Biology, Institute for Biology, Freie Universität Berlin, 14195 Berlin, Germany.
  • Animal Health Research Institute, Agriculture Research Centre, 12618 Cairo, Egypt.
  • Berlin-Brandenburg Institute of Advanced Biodiversity Research (BBIB), Berlin, Germany.

ORCID-Profile: Mohammed Elbediwi

Förderung

  • Freie Universität Berlin

Zitieren

APA

Elbediwi, M., & Rolff, J. (2024). Metabolic pathways and antimicrobial peptide resistance in bacteria. Journal of Antimicrobial Chemotherapy, 79(7), 1473-1483. https://doi.org/10.1093/jac/dkae128

Vancouver

Elbediwi M, Rolff J. Metabolic pathways and antimicrobial peptide resistance in bacteria. Journal of Antimicrobial Chemotherapy. 2024;79(7):1473-1483. doi:10.1093/jac/dkae128

BibTeX
@article{Elbediwi2024,
  author = {Elbediwi, Mohammed and Rolff, Jens},
  title = {Metabolic pathways and antimicrobial peptide resistance in bacteria},
  journal = {Journal of Antimicrobial Chemotherapy},
  year = {2024},
  volume = {79},
  number = {7},
  pages = {1473--1483},
  doi = {10.1093/jac/dkae128}
}
Kostenlos starten →